ReviewBiosensors2025
A Review on 3D-Printed Miniaturized Devices for Point-of-Care-Testing Applications.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A Sustainable 3D-Printed Electrochemiluminescence Microcell With an Integrated Three-Electrode System for Gallic Acid Determination.Luminescence : the journal of biological and chemical luminescence · 2026Article
- Cell-Based Biosensors in Oral Health: Emerging Tools for Rapid Detection and Monitoring of Oral Diseases.Biosensors · 2026Review
- Point-of-Care Electrochemical Diagnostic Developments for Multidrug-Resistant Bacteria: Role of Aptamers and Nanomaterials.Biosensors · 2026Review
- Electrochemical and optical biosensors for periodontitis detection.Biochemistry and biophysics reports · 2026Review
- Review
- The Collapse of Brain Clearance: Glymphatic-Venous Failure, Aquaporin-4 Breakdown, and AI-Empowered Precision Neurotherapeutics in Intracranial Hypertension.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Integrating three-dimensional printing (3DP) in healthcare has modernized medical diagnostics and therapies by presenting various accurate, efficient, and patient-specific tailored solutions. This review critically examines the integration of 3DP in the development of miniaturized devices specifically tailored for point-of-care testing (PoCT) applications in healthcare. Focusing on progressive additive manufacturing techniques, such as material extrusion, vat photopolymerization, and powder bed fusion, the review classifies and evaluates their contributions toward designing compact, portable, and patient-specific diagnostic devices. Unlike previous reviews that treat 3DP or PoCT generically, this work uniquely bridges the technical innovations of 3DP with clinical applications by analyzing wearable sensors, biosensors, lab-on-chip systems, and microfluidic platforms. It highlights recent case studies, performance metrics, and the role of 3DP in enhancing diagnostic speed, accessibility, and personalization. The review also explores challenges such as material standardization and regulatory hurdles while outlining future directions involving artificial intelligence (AI), the Internet of Things (IoT), and multifunctional integration. This focused assessment establishes 3DP as a transformative force in decentralized and precision healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.